theflyonthewall.com: the Fastest Breaking Financial and Equity News on the Web

News Breaks

September 30, 2009

14:36 EDT

BIOD

theflyonthewall.com:		Biodel has major value drivers in 2010-2011, says Wedbush
		Wedbush believes the FDA will accept Biodel's VIAject NDA filing in Q1 of next year and approve it by the first half of 2011. The firm also thinks a partnership could occur in the second half of 2010. Wedbush reiterates an Outperform rating on the stock with a $17 price target. :theflyonthewall.com

News For BIOD From The Last 14 Days

Check below for free stories on BIOD the last two weeks.

There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.

February 8, 2012

16:06 EDT

BIOD

theflyonthewall.com:		Biodel reports Q1 R&D expenses $2.4M compared to $5.5 a year ago
		:theflyonthewall.com

16:06 EDT

BIOD

theflyonthewall.com:		Biodel reports Q1 EPS (12c) vs. consensus (14c)
		Subscribe for More Information :theflyonthewall.com